The method of embodiment 134, wherein the composition comprises between about 0.01% to about 20% by weight of the poloxamer, about 0.01% to about 15% by weight of the poloxamer, about 0.01% to about 10% by weight of the poloxamer, about 0.01% to about 7% by weight of the poloxamer, about 0.01% to about 5% by weight of the poloxamer, about 0.01% to about 3% by weight of the poloxamer, about 0.01% to about 2% by weight of the poloxamer, or about 0.01% to about 1% by weight of the poloxamer
The levels of proinflammatory cytokines (such as IL-1, IL-6, IL-8, IL-12p40, IFN-, TNF- and GM-CSF) are increased, while those of anti-inflammatory cytokines (such as IL-10 and TGF-) are decreased, in the blood of ASD patients
Excess B vitamins are excreted by the kidneys through the urine, causing bright yellow urine
Can MIC+B12 injections improve mood and focus
CCL2, CC motif ligand 2